Jilin Aodong Pharmaceutical Group Co., Ltd. (SHE:000623)
China
· Delayed Price · Currency is CNY 18.67
+0.13 (0.70%)
Apr 29, 2026, 3:04 PM CST
SHE:000623 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 21,736 | 22,897 | 20,653 | 17,098 | 17,020 | 21,034 | Upgrade
|
| Market Cap Growth | 10.42% | 10.86% | 20.79% | 0.46% | -19.09% | 10.96% | Upgrade
|
| Enterprise Value | 21,232 | 22,283 | 20,126 | 16,961 | 16,158 | 19,596 | Upgrade
|
| Last Close Price | 18.54 | 19.53 | 16.80 | 13.91 | 13.52 | 16.33 | Upgrade
|
| PE Ratio | 9.08 | 9.56 | 13.31 | 11.71 | 9.56 | 11.81 | Upgrade
|
| PS Ratio | 9.31 | 9.81 | 7.91 | 4.96 | 5.93 | 9.13 | Upgrade
|
| PB Ratio | 0.70 | 0.74 | 0.71 | 0.62 | 0.65 | 0.84 | Upgrade
|
| P/TBV Ratio | 0.72 | 0.76 | 0.72 | 0.64 | 0.66 | 0.86 | Upgrade
|
| P/FCF Ratio | 151.14 | 159.22 | - | - | 111.32 | 1821.95 | Upgrade
|
| P/OCF Ratio | 79.84 | 84.10 | 347.21 | 251.22 | 40.15 | 64.75 | Upgrade
|
| EV/Sales Ratio | 9.09 | 9.54 | 7.71 | 4.92 | 5.63 | 8.51 | Upgrade
|
| EV/EBITDA Ratio | - | 859.61 | 431.72 | 49.91 | 49.49 | 97.79 | Upgrade
|
| EV/EBIT Ratio | - | - | - | 126.08 | 124.38 | 3339.39 | Upgrade
|
| EV/FCF Ratio | 147.64 | 154.95 | - | - | 105.68 | 1697.40 | Upgrade
|
| Debt / Equity Ratio | 0.07 | 0.07 | 0.08 | 0.11 | 0.11 | 0.10 | Upgrade
|
| Debt / EBITDA Ratio | 46.36 | 46.36 | 30.89 | 8.23 | 8.41 | 12.45 | Upgrade
|
| Debt / FCF Ratio | 15.57 | 15.57 | - | - | 19.56 | 226.58 | Upgrade
|
| Net Debt / Equity Ratio | -0.02 | -0.02 | -0.01 | -0.01 | -0.03 | -0.08 | Upgrade
|
| Net Debt / EBITDA Ratio | -27.93 | -27.93 | -8.28 | -1.02 | -2.68 | -10.08 | Upgrade
|
| Net Debt / FCF Ratio | -5.03 | -5.03 | 1.80 | 0.99 | -5.73 | -174.93 | Upgrade
|
| Asset Turnover | 0.07 | 0.07 | 0.08 | 0.11 | 0.10 | 0.08 | Upgrade
|
| Inventory Turnover | 1.46 | 1.46 | 1.77 | 2.02 | 1.93 | 1.95 | Upgrade
|
| Quick Ratio | 1.98 | 1.98 | 1.57 | 1.08 | 2.25 | 3.89 | Upgrade
|
| Current Ratio | 2.40 | 2.40 | 1.96 | 1.29 | 2.70 | 4.35 | Upgrade
|
| Return on Equity (ROE) | 7.85% | 7.85% | 5.35% | 5.37% | 7.01% | 7.29% | Upgrade
|
| Return on Assets (ROA) | -0.31% | -0.31% | -0.31% | 0.27% | 0.27% | 0.01% | Upgrade
|
| Return on Invested Capital (ROIC) | -0.54% | -0.55% | -0.57% | 0.49% | 0.54% | 0.03% | Upgrade
|
| Return on Capital Employed (ROCE) | -0.50% | -0.50% | -0.50% | 0.50% | 0.40% | 0.00% | Upgrade
|
| Earnings Yield | 11.02% | 10.46% | 7.51% | 8.54% | 10.46% | 8.46% | Upgrade
|
| FCF Yield | 0.66% | 0.63% | -1.04% | -2.06% | 0.90% | 0.06% | Upgrade
|
| Dividend Yield | 2.70% | 2.56% | 2.98% | 4.31% | 2.22% | 1.84% | Upgrade
|
| Payout Ratio | 27.10% | 27.10% | 68.33% | 27.44% | 21.21% | 14.36% | Upgrade
|
| Buyback Yield / Dilution | 0.34% | 0.34% | 9.08% | 0.46% | -3.36% | 1.39% | Upgrade
|
| Total Shareholder Return | 3.15% | 2.90% | 12.06% | 4.77% | -1.14% | 3.22% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.